Opioids And Psychic Pain: Alkermes Uses High-Profile Stage To Highlight Depression Drug

Biopharma companies working on non-addictive pain drugs and new therapies to treat addiction had a high-profile platform during the most recent meeting of the President’s Commission on opioid abuse. Alkermes made the most of the opportunity.